The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Export 11032 results:
[ Author(Desc)] Title Type Year
Filters: Filter is   [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
K
Kountouras, J., Chatzopoulos D., Zavos C., Deretzi G., Polyzos S. A., Gavalas E., et al. (2012).  Ki-67 and Bax expression in esophageal mucosa might have implications in ablative therapies for Barrett's esophagus, dysplasia, and adenocarcinoma.. Surg Endosc. 26(1), 283-4.
Kountouras, J., Papaefthymiou A., Polyzos S. A., Kazakos E., Tzilves D., Lazaraki G., et al. (2023).  Potential impact of Helicobacter pylori infection on hepatic steatosis and metabolic risk factors among patients with chronic hepatitis B.. J Viral Hepat.
Kountouras, J., Zavos C., Deretzi G., Polyzos S. A., Katsinelos P., Anastasiadou K., et al. (2011).  Helicobacter pylori might be a potential therapeutic target in epilepsy.. Med Hypotheses. 76(5), 763.
Kountouras, J., Polyzos S. A., Zavos C., Kapetanakis N., Pilpilidis I., Vrettos M., et al. (2015).  Bone Marrow-Derived Stem Cells in Pathogenesis of Helicobacter pylori-Associated Gastrointestinal Cancer.. Clin Transl Gastroenterol. 6, e129.
Kountouras, J., Polyzos S. A., Kapetanakis N., Katsinelos P., Nikolopoulos P., Stogianni A., et al. (2017).  Letter: Helicobacter pylori-related non-alcoholic fatty liver disease with concomitant metabolic syndrome as risk factor for colorectal neoplasia.. Aliment Pharmacol Ther. 45(4), 576-577.
Kountouras, J., Doulberis M., Papaefthymiou A., & Polyzos S. A. (2020).  Impact of Helicobacter pylori-linked metabolic syndrome on non-alcoholic fatty liver disease and its connected atrial fibrillation risk.. Liver Int.
Kountouras, J., Zavos C., Polyzos S. A., Katsinelos P., & Stergiopoulos C. (2014).  Eradication of Helicobacter pylori infection might have a positive impact on subpopulations with endoscopic gastro-oesophageal reflux disease.. Eur J Gastroenterol Hepatol. 26(1), 123.
Kountouras, J., Papaefthymiou A., Polyzos S. A., Liatsos C., Zavos C., Vagdatli E., et al. (2020).  Potential Impact of Helicobacter pylori Infection on Reflux Disease Sequence: Illuminating the Gap.. J Clin Gastroenterol. 54(2), 200-201.
Kountouras, J., Kapetanakis N., Zavos C., Polyzos S. A., Kouklakis G., Venizelos I., et al. (2014).  Active Helicobacter pylori infection is associated with colorectal mucosa-adenomatous polyp--early and advanced adenocarcinoma sequence.. Scand J Gastroenterol. 49(3), 381-2.
Kountouras, J., Zavos C., Polyzos S. A., Michael S., Tsiaousi E., Vardaka E., et al. (2013).  Relationship between Helicobacter pylori infection and autoimmune disorders.. Clin Chem Lab Med. 51(5), e73-4.
Kountouras, J., Polyzos S. A., Katsinelos P., Anastasiadis S., Tzivras D., Doulberis M., et al. (2018).  Potential Impact of Helicobacter Pylori on Hepatic Encephalopathy Pathophysiology.. Dig Dis Sci. 63(4), 1087-1088.
Kountouras, J., Polyzos S. A., Grigoriadis N., & Deretzi G. (2015).  Helicobacter Pylori-Related Vitamin B12 Deficiency: A Potential Contributor in Neuropsychiatric Disorders.. Indian J Psychol Med. 37(4), 475-6.
Kountouras, J., Polyzos S. A., Katsinelos P., Zeglinas C., Artemaki F., Tzivras D., et al. (2017).  Cardio-cerebrovascular disease and Helicobacter pylori-related metabolic syndrome: We consider eradication therapy as a potential cardio-cerebrovascular prevention strategy.. Int J Cardiol. 229, 17-18.
Kountouras, J., Papaefthymiou A., Doulberis M., Polyzos S. A., Zavos C., Kazakos E., et al. (2021).  Impact of Helicobacter pylori-related Metabolic Syndrome and Gastroesophageal Reflux Disease on the Risk of Acute Myocardial Infarction.. J Neurogastroenterol Motil. 27(1), 147-148.
Kountouras, J., Gavalas E., Doulberis M., Polyzos S. A., Papaefthimiou A., Touloumtsi M., et al. (2019).  The Effect of Trimebutine and/or Helicobacter pylori Eradication on the Gastroesophageal Reflux Disease, Irritable Bowel Syndrome, and Functional Dyspepsia Overlapping Disorders.. J Neurogastroenterol Motil.
Kountouras, J., Polyzos S. A., Zeglinas C., Katsinelos P., Giorgakis N., Vardaka E., et al. (2016).  Helicobacter pylori infection and oesophageal adenocarcinoma.. Cancer Epidemiol. 42, 206-7.
Kountouras, J., Boziki M., Gavalas E., Zavos C., Deretzi G., Grigoriadis N., et al. (2009).  Increased cerebrospinal fluid Helicobacter pylori antibody in Alzheimer's disease.. Int J Neurosci. 119(6), 765-77.
Kountouras, J., Polyzos S. A., Katsinelos P., Zeglinas C., Artemaki F., Tzivras D., et al. (2017).  Helicobacter pylori eradication to prevent cardio-cerebrovascular disease: Are current data useful for clinical practice?. Int J Cardiol. 233, 92.
Kountouras, J., Doulberis M., Polyzos S. A., Papaefthymiou A., Kapetanakis N., Arapoglou S., et al. (2018).  Potential Impact of Active Helicobacter pylori Infection with or without Concomitant Metabolic Syndrome on Colorectal Cancer Invasion and Mortality.. Isr Med Assoc J. 20(11), 725-726.
Kountouras, J., Polyzos S. A., & Deretzi G. (2015).  Helicobacter pylori Associated With Obstructive Sleep Apnea Might Contribute to Sleep, Cognition, and Driving Performance Disturbances in Patients With Cirrhosis.. Clin Gastroenterol Hepatol. 13(8), 1547.
Kountouras, J., Papaefthymiou A., Polyzos S. A., Liatsos C., Vardaka E., Touloumtzi M., et al. (2022).  Letter to the Editor Regarding "The Association of Helicobacter pylori, Eradication, and Early Complications of Laparoscopic Sleeve Gastrectomy" by Abeid et al.. Obes Surg. 32(6), 2079-2080.
Kountouras, J., Papaefthymiou A., Polyzos S. A., Deretzi G., Vardaka E., Soteriades E. S., et al. (2021).  Impact of -Related Metabolic Syndrome Parameters on Arterial Hypertension.. Microorganisms. 9(11), 
Kountouras, J., Zavos C., Polyzos S. A., Deretzi G., Vardaka E., Giartza-Taxidou E., et al. (2012).  Helicobacter pylori infection and Parkinson's disease: apoptosis as an underlying common contributor.. Eur J Neurol. 19(6), e56.
Kountouras, J., Polyzos S. A., & Deretzi G. (2018).  Multiple Bidirectionality Brain-Gut Interactions in Patients With Inflammatory Bowel Disease.. Gastroenterology. 155(5), 1651-1652.
Kountouras, J., Doulberis M., Papaefthimiou A., & Polyzos S. A. (2019).  Gastroesophageal reflux disease, irritable bowel syndrome and functional dyspepsia as overlapping conditions: focus on effect of trimebutine.. Ann Gastroenterol. 32(3), 318.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.